1)日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧診療ガイドライン2019.p. viii, pp. 4-5, 52-53 https://www.jpnsh.jp/data/jsh2019/JSH2019_noprint.pdf(2022年6月閲覧)
2)Fujiyoshi A, et al;Observational Cohorts in Japan(EPOCH-JAPAN)Research Group:Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res 35:947-963, 2012
3)Satoh A, et al;NIPPON DATA 2010 Research Group:Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population;NIPPON DATA2010. J Hypertens 35:401-408, 2017
4)Whelton PK, et al:2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults;A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guideline. Hypertension 71:e13-e115, 2018
5)Unger T, et al:2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 75:1334-1357, 2020
6)Donald EC Jr, et al:2019 AHA/ACC clinical performance and quality measures for adults with high blood pressure;A report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol 74:2661-2706, 2019
7)The SPRINT Research Group:A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103-2116, 2015
8)Blood Pressure Lowering Treatment Trialist's Collaboration:Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death;And individual participant-level deta meta-anaylsis. Lancet 398:1053-1064, 2021
9)桑島 巌:高齢者高血圧論争を振り返る—その3降圧薬の今昔.医事新報5018:32-35, 2020